|
|||||
|
|
Golimumab improves socio economic and health economic parameters in patients with rheumatoid arthritis,psoriatic arthritis,and ankylosing spondylitis |
|
| Authors: | Klaus Krüger Gerd Rüdiger Burmester Siegfried Wassenberg |
| Affiliation: | 1. Praxiszentrum St. Bonifatius München, Munich, Germany;2. Charité-University Medicine Berlin, Berlin, Germany;3. Rheumazentrum Ratingen, Ratingen, Germany |
| Abstract: | Abstract BackgroundGolimumab (GLM) has shown its efficacy and safety in various clinical trials. We aimed to assess the effect of GLM on socio economic and health economic parameters in daily clinical practice. |
| Keywords: | Socio economic health economic biologicals rheumatoid arthritis psoriatic arthritis ankylosing spondylitis TNF-inhibitor and Golimumab |